Anterix (ATEX) Current Deferred Revenue (2016 - 2025)

Anterix's Current Deferred Revenue history spans 12 years, with the latest figure at $7.9 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 93.76% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $7.9 million, down 93.76%, while the annual FY2025 figure was $6.1 million, 95.01% down from the prior year.
  • Current Deferred Revenue reached $7.9 million in Q4 2025 per ATEX's latest filing, down from $130.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $130.4 million in Q3 2025 to a low of $737000.0 in Q2 2021.
  • Average Current Deferred Revenue over 5 years is $55.1 million, with a median of $54.3 million recorded in 2022.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 7219.54% in 2022, then tumbled 95.01% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $1.5 million in 2021, then surged by 441.27% to $8.0 million in 2022, then dropped by 13.75% to $6.9 million in 2023, then soared by 1726.97% to $126.1 million in 2024, then tumbled by 93.76% to $7.9 million in 2025.
  • Per Business Quant, the three most recent readings for ATEX's Current Deferred Revenue are $7.9 million (Q4 2025), $130.4 million (Q3 2025), and $128.2 million (Q2 2025).